Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Louis Nickolaus Jungheim"'
Autor:
Zahid Quyoom Bonday, Bomie Han, Louis Nickolaus Jungheim, Aiping Zhang, Marijane Russell, Kenneth Weichert, Brandon Doyle, Tarun Gheyi, Francis S. Willard, Stephen Antonysamy, J. Michael Sauder, S. Emtage, Zhanna Druzina, Charles Rauch, Robert M. Campbell, Yuewei Qian, S.R. Wasserman
Publikováno v:
Proceedings of the National Academy of Sciences. 109:17960-17965
Protein arginine methyltransferases (PRMTs) play important roles in several cellular processes, including signaling, gene regulation, and transport of proteins and nucleic acids, to impact growth, differentiation, proliferation, and development. PRMT
Autor:
Tracy D. Self, Peter Ambrose Lander, Bryan H. Norman, Louis Nickolaus Jungheim, Jeffrey Daniel Cohen, Joseph Michael Gruber, Donald C. Paul, James J. Starling, Julian Stanley Kroin, Linda B. Tabas, Anne H. Dantzig, Daniel C. Williams, Kevin L. Law
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:5526-5530
Structure–activity relationship (SAR) studies on the tricyclic isoxazole series of MRP1 modulators have resulted in the identification of potent and selective inhibitors containing cyclohexyl-based linkers. These studies ultimately identified compo
Autor:
Brian Stephen Muehl, Silke Voelkers, Gerd Ruehter, Kenneth Jeff Thrasher, Dirk Hankotius, Hans-Juergen Mest, Soenke Petersen, Martina Berg, Grit Riedel-Herold, Jeffrey Alan Dodge, Louis Nickolaus Jungheim, Britta Evers, Mark Joseph Tebbe, Ulrike Hary, Eva-Maria Martin de la Nava, Birgit Sommer, Michael Mohr
Publikováno v:
Bioorganic & Medicinal Chemistry. 13:6748-6762
A series of growth hormone secretagogues (GHSs) based on 2,3-dihydroisothiazole has been synthesized in the search for a potential treatment of growth hormone deficiency or frailty in the elderly. This paper describes the evaluation of the SAR of the
Autor:
Robert B. Johnson, Jeffrey Daniel Cohen, Q. May Wang, Louis Nickolaus Jungheim, Elcira C. Villarreal
Publikováno v:
Antimicrobial Agents and Chemotherapy. 42:916-920
The 2A and 3C proteases encoded by human rhinoviruses (HRVs) are attractive targets for antiviral drug development due to their important roles in viral replication. Homophthalimides were originally identified as inhibitors of rhinovirus 3C protease
Autor:
Quiping Wang, JM Richardson, Robert B. Johnson, Jeffrey Daniel Cohen, GT Voy, Louis Nickolaus Jungheim
Publikováno v:
Antiviral Chemistry and Chemotherapy. 8:303-310
Rhinovirus 3C protease is an attractive target for therapeutic intervention owing to its important role in virion maturation and infectivity. In order to facilitate the identification of potential 3C protease inhibitors, we have developed a continuou
Autor:
Loncharich Richard James, Louis Nickolaus Jungheim, Q. May Wang, Jeffrey Daniel Cohen, Mark Wakulchik, Robert B. Johnson, Elcira C. Villarreal
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:1589-1594
Homophthalimides 2a and 3a were found to be inhibitors of Rhinovirus 3C protease through a blind screening effort. SAR studies resulted in compound 3g, which exhibited improved enzyme inhibition, in addition to whole cell antiviral activity. Molecula
Autor:
S. D. Hatch, Mark A. Muesing, Penny P. Lubbehusen, Jeffrey A. Burgess, Angela J. Baxter, Louis Nickolaus Jungheim, Timothy Alan Shepherd, M. Wiskerchen
Publikováno v:
Journal of Medicinal Chemistry. 39:96-108
Noncoded D-amino acids have been designed to replace the quinaldic amide-asparaginyl moiety (P 2 /P 3 ligand) found in several potent human immunodeficiency virus (HIV) protease inhibitors such as LY289612. The substituted nitrogen, optimally an N-me
Autor:
Timothy Alan Shepherd, Angela J. Baxter, Kristina M. Campanale, Kenneth S. Su, M. Wiskerchen, John E. Munroe, J. M. Colacino, William Joseph Hornback, Mark A. Muesing, Louis Nickolaus Jungheim, S. D. Hatch
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:2897-2902
Novel noncoded D-amino acids have been combined with decahydroisoquinoline, octahydrothienopyridine, and urea hydroxyethylamine isosteres to provide potent HIV-1 protease inhibitors with excellent HIV-1 antiviral activity. LY314613 shows a promising
Publikováno v:
Chemical Reviews. 94:1553-1566
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:1391-1396
Noncoded D-amino acids have been synthesized which effectively replace the P2/P3 ligands of the HIV-1 protease inhibitor LY289612. Several analogues are shown to have potent enzyme inhibitory and antiviral activities.